Clinical and Healthcare Outcomes From Real-World Use in the United States of a Companion AI During AF Ablation
Sponsored by Volta Medical
About this study
Observational, multi-center, clinical device registry for US patients with a primary goal to observe the clinical outcomes in patients who are mapped with Volta Medical's VX1 or AF-Xplorer systems during AF ablation procedures.
Where this study is enrolling (2)
- I'm interested
Endeavor Health
Evanston, Illinois
- I'm interested
Kansas City Cardiac Arrhythmia Research LLC
Overland Park, Kansas
Who can participate
Inclusion criteria
- ✓1. Patients 21 years of age or older who is:
- ✓indicated for AF ablation or
- ✓Who has received an AF-ablation with the past 24 months where VX1 was used or
- ✓2. Patients are receiving or received a catheter ablation procedure for AF according to current guidelines
- ✓3. Patients must be able and willing to provide written informed consent to participate in the clinical trial
Exclusion criteria
- ✕1. Patients not indicated or were not indicated for catheter ablation according to current guidelines
- ✕2. Patients with AF secondary to an obvious reversible cause
- ✕3. Patients who are or may potentially be pregnant
- ✕4. Enrollment in an investigational study evaluating another non-VX1 investigational device, biologic, or drug
Only the research team can confirm whether you qualify. The intake questionnaire is the best way to find out.
Completing a questionnaire on Clinably does not enroll you in a clinical trial or confirm your eligibility. Only the research team can determine whether you qualify to participate. These results are based on the information you provide and are intended to help you start a conversation with the research team.
Trial data sourced from ClinicalTrials.gov.